• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非结核分枝杆菌引起的腹膜透析相关性感染的诊断、预后和治疗的系统文献回顾。

Systematic literature review of the diagnosis, prognosis, and treatment of peritoneal dialysis-related infection caused by nontuberculous mycobacteria.

机构信息

Department of Nephrology, St. Luke's International Hospital, Tokyo, Japan.

Department of Infectious Diseases, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan.

出版信息

BMC Nephrol. 2024 Nov 28;25(1):432. doi: 10.1186/s12882-024-03841-2.

DOI:10.1186/s12882-024-03841-2
PMID:39609738
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11606208/
Abstract

The number of peritoneal dialysis (PD) catheter-related infections and peritonitis caused by nontuberculous mycobacteria (NTM) has been increasing. Nonetheless, the optimal timing for the relocation of the exit site, removal and reinsertion of the PD catheter, prognosis, and duration of antibiotic treatment remain unclear. This literature review aimed to investigate the epidemiology of patient characteristics and evaluate the most effective diagnostic and treatment strategies for PD catheter-related infections and peritonitis caused by NTM. The systematic literature review was conducted on published cases of PD catheter-related infection and peritonitis caused by NTM in PubMed, Embase, and Ichushi databases up to August 2022. A total of 335 cases (64.1%, male; mean age, 53.4 years; mean dialysis duration, 25.4 months) were analyzed. The most common causative agent of infection was Mycobacterium abscessus (40.1%), followed by Mycobacterium fortuitum (24.8%) and Mycobacterium chelonae (16.6%). With respect to diagnosis, 42.9%, 28.1%, and 29.0% of cases were diagnosed as PD catheter-related infection only, peritonitis only, and both, respectively. The initial cultures were positive for NTM only, positive for any other bacteria, and negative for NTM only in 56.5%, 19.8%, and 23.7% of cases, respectively. Ultimately, more than 80% of cases were treated with multiple antibiotics. PD catheter removal was performed in 55.4% of patients with PD catheter-related infections only and 85.5% of those with PD peritonitis. PD continuation or resumption was possible in 62.2% and 16.0% of patients, respectively. In conclusion, our findings indicate that it is advisable to perform acid-fast bacilli stain and culture in order to promptly identify NTM. PD catheter removal may be an essential management strategy during the early stages of NTM infection.

摘要

腹膜透析(PD)导管相关感染和非结核分枝杆菌(NTM)引起的腹膜炎的数量一直在增加。然而,对于出口部位的重新定位、PD 导管的移除和重新插入、预后以及抗生素治疗的持续时间,最佳时机仍不清楚。本文献综述旨在调查患者特征的流行病学,并评估治疗 NTM 引起的 PD 导管相关感染和腹膜炎的最有效诊断和治疗策略。系统文献综述在 PubMed、Embase 和 Ichushi 数据库中检索了截至 2022 年 8 月发表的与 NTM 引起的 PD 导管相关感染和腹膜炎相关的病例,并进行了文献综述。共分析了 335 例(64.1%,男性;平均年龄 53.4 岁;平均透析时间 25.4 个月)。感染的最常见病原体是脓肿分枝杆菌(40.1%),其次是偶然分枝杆菌(24.8%)和溃疡分枝杆菌(16.6%)。在诊断方面,分别有 42.9%、28.1%和 29.0%的病例仅被诊断为 PD 导管相关感染、腹膜炎和两者均有。最初的培养物中仅分枝杆菌阳性、其他任何细菌阳性和分枝杆菌阴性的比例分别为 56.5%、19.8%和 23.7%。最终,超过 80%的病例接受了多种抗生素治疗。在仅 PD 导管相关感染的患者中有 55.4%和在仅 PD 腹膜炎的患者中有 85.5%的患者进行了 PD 导管移除。PD 继续或恢复的可能性分别为 62.2%和 16.0%。总之,我们的研究结果表明,及时进行抗酸杆菌染色和培养以快速识别 NTM 是明智的。在 NTM 感染的早期阶段,PD 导管移除可能是一种重要的管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405a/11606208/b970d2323403/12882_2024_3841_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405a/11606208/d63a39d3d1a1/12882_2024_3841_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405a/11606208/b970d2323403/12882_2024_3841_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405a/11606208/d63a39d3d1a1/12882_2024_3841_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405a/11606208/b970d2323403/12882_2024_3841_Fig2_HTML.jpg

相似文献

1
Systematic literature review of the diagnosis, prognosis, and treatment of peritoneal dialysis-related infection caused by nontuberculous mycobacteria.非结核分枝杆菌引起的腹膜透析相关性感染的诊断、预后和治疗的系统文献回顾。
BMC Nephrol. 2024 Nov 28;25(1):432. doi: 10.1186/s12882-024-03841-2.
2
Peritoneal dialysis-associated infection caused by Mycobacterium abscessus: a case report.腹腔透析相关性脓肿分枝杆菌感染:一例报告。
BMC Nephrol. 2018 Nov 29;19(1):341. doi: 10.1186/s12882-018-1148-2.
3
Nontuberculous mycobacteria infections of peritoneal dialysis patients: A multicenter study.腹膜透析患者非结核分枝杆菌感染:一项多中心研究。
Perit Dial Int. 2021 May;41(3):284-291. doi: 10.1177/0896860820923461. Epub 2020 May 13.
4
Simultaneous catheter removal and reinsertion, is it acceptable in M. abscessus exit site infection?同时进行导管移除和再插入,在 M. abscessus 出口部位感染中是否可行?
CEN Case Rep. 2021 Nov;10(4):483-489. doi: 10.1007/s13730-021-00593-y. Epub 2021 Mar 16.
5
The clinical course of rapidly growing nontuberculous mycobacterial peritoneal dialysis infections in Asians: A case series and literature review.亚洲人快速生长非结核分枝杆菌性腹膜透析感染的临床病程:病例系列和文献复习。
Nephrology (Carlton). 2011 Feb;16(2):174-9. doi: 10.1111/j.1440-1797.2010.01370.x.
6
Peritoneal dialysis-associated nontuberculous mycobacterium peritonitis: a systematic review of reported cases.与腹膜透析相关的非结核分枝杆菌性腹膜炎:已报告病例的系统综述。
Nephrol Dial Transplant. 2012 Apr;27(4):1639-44. doi: 10.1093/ndt/gfr504. Epub 2011 Sep 2.
7
Mycobacterium fortuitum peritonitis in peritoneal dialysis and its effects on the peritoneum.腹膜透析中的偶然分枝杆菌腹膜炎及其对腹膜的影响。
Clin Nephrol. 2014 Nov;82(5):341-6. doi: 10.5414/CN107704.
8
Non-Tuberculous Mycobacterial Infections Related to Peritoneal Dialysis.与腹膜透析相关的非结核分枝杆菌感染
Perit Dial Int. 2018 Mar-Apr;38(2):147-149. doi: 10.3747/pdi.2017.00172.
9
The Role of Non-Tuberculous Mycobacteria in Peritoneal Dialysis-Related Infections: A Literature Review.非结核分枝杆菌在腹膜透析相关感染中的作用:文献综述
Contrib Nephrol. 2018;196:155-161. doi: 10.1159/000485716. Epub 2018 Jul 24.
10
Peritoneal dialysis-associated infection caused by Mycobacterium abscessus in a pediatric patient on continuous peritoneal dialysis without switching to hemodialysis.儿童患者在持续腹膜透析而未转为血液透析的情况下发生脓肿分枝杆菌引起的腹膜透析相关性感染。
CEN Case Rep. 2024 Dec;13(6):463-467. doi: 10.1007/s13730-024-00875-1. Epub 2024 Apr 6.

引用本文的文献

1
A case report of peritoneal dialysis-associated peritonitis caused by .一例由……引起的腹膜透析相关性腹膜炎病例报告
IJID Reg. 2025 May 7;15:100659. doi: 10.1016/j.ijregi.2025.100659. eCollection 2025 Jun.

本文引用的文献

1
ISPD Catheter-related Infection Recommendations: 2023 Update.国际腹膜透析学会导管相关性感染推荐:2023 更新版。
Perit Dial Int. 2023 May;43(3):201-219. doi: 10.1177/08968608231172740. Epub 2023 May 26.
2
Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease.氟喹诺酮高剂量治疗与晚期慢性肾脏病老年患者严重不良事件的相关性。
JAMA Netw Open. 2022 Aug 1;5(8):e2224892. doi: 10.1001/jamanetworkopen.2022.24892.
3
ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment.
国际腹膜透析学会(ISPD)腹膜炎指南建议:2022年预防与治疗更新版
Perit Dial Int. 2022 Mar;42(2):110-153. doi: 10.1177/08968608221080586.
4
Simultaneous catheter removal and reinsertion, is it acceptable in M. abscessus exit site infection?同时进行导管移除和再插入,在 M. abscessus 出口部位感染中是否可行?
CEN Case Rep. 2021 Nov;10(4):483-489. doi: 10.1007/s13730-021-00593-y. Epub 2021 Mar 16.
5
The Role of Non-Tuberculous Mycobacteria in Peritoneal Dialysis-Related Infections: A Literature Review.非结核分枝杆菌在腹膜透析相关感染中的作用:文献综述
Contrib Nephrol. 2018;196:155-161. doi: 10.1159/000485716. Epub 2018 Jul 24.
6
Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.使用新一代大环内酯类、氟喹诺酮类和β-内酰胺/β-内酰胺酶抑制剂的患者发生心律失常和死亡的风险:一项台湾全国性研究。
Clin Infect Dis. 2015 Feb 15;60(4):566-77. doi: 10.1093/cid/ciu914. Epub 2014 Nov 18.
7
Rapidly growing mycobacterial bloodstream infections.快速生长分枝杆菌血流感染。
Lancet Infect Dis. 2013 Feb;13(2):166-74. doi: 10.1016/S1473-3099(12)70316-X.
8
Incubation time of mycobacterial cultures: how long is long enough to issue a final negative report to the clinician?分枝杆菌培养的孵育时间:向临床医生出具最终阴性报告需要多长时间才足够?
J Clin Microbiol. 2012 Dec;50(12):4188-9. doi: 10.1128/JCM.02283-12. Epub 2012 Oct 10.
9
Atypical mycobacterial exit-site infection and peritonitis in peritoneal dialysis patients on prophylactic exit-site gentamicin cream.预防性应用出口部位庆大霉素乳膏的腹膜透析患者中的非典型分枝杆菌出口部位感染和腹膜炎。
Perit Dial Int. 2013 May-Jun;33(3):267-72. doi: 10.3747/pdi.2011.00184. Epub 2012 Oct 2.
10
Mycobacterium chelonae peritonitis in a patient on peritoneal dialysis.一名接受腹膜透析患者的龟分枝杆菌腹膜炎
Ren Fail. 2008;30(3):335-8. doi: 10.1080/08860220701861185.